During the past decade, XiaMen Heart Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "XiaMen Heart Center" are "Coronary Artery Disease" (1 trials), "Sudden Cardiac Arrest" (1 trials) and "Ventricular Arrythmia" (1 trials). Many other conditions were trialed in "XiaMen Heart Center" in a lesser frequency.

Most popular intervention types in "XiaMen Heart Center" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Heart-protecting Musk Pill" (1 trials), "ICD or CRT-D Device" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "XiaMen Heart Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "XiaMen Heart Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in XiaMen Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in XiaMen Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".